+1 877 705 1914• 24 / 7
HIPAA Compliant
ISO 27001 Certified

Actively Recruiting

Phase Not Applicable
Age: 22Years - 84Years
All Genders
ID07719608

Randomized, Controlled Trial to Assess the MySalvia Neuromodulation System for Preventing Resistant Migraine in Adults

Led by Salvia BioElectronics · Updated on 2026-08-28

150

Participants Needed

3

Research Sites

134 weeks

Total Duration

AI-Summary

What This Trial Is About

Researchers are evaluating the safety and effectiveness of the MySalvia System, a minimally invasive implantable neuromodulation device, for preventing migraines in adults who have resistant migraine. This pivotal clinical trial focuses on adults aged 22 to 84 years who have chronic and difficult-to-treat migraine conditions, including migraines with or without aura. The study is randomized, double-blind, and controlled to thoroughly assess the devices impact. Participants will be randomly assigned to receive either the active MySalvia neurostimulator system or an active control. The device delivers mild electrical signals to targeted craniofacial nerves through implantable and non-implantable components. The study includes a 24-week treatment period where efficacy and safety are closely monitored. This trial excludes those using other neuromodulation devices or with certain implantable medical devices nearby. Throughout the study, participants will have regular assessments to monitor migraine frequency, severity, and any side effects. Evaluations include tracking changes in monthly migraine days and monitoring for adverse events related to the device. The primary outcomes focus on both the effectiveness of migraine prevention and the safety of the neurostimulator over the 24-week period. Participants will be involved for the duration of treatment and follow-up until study completion in 2031.

CONDITIONS

Brief Title

A Pivotal Clinical Study to Evaluate the MySalvia System for the Treatment of Resistant Migraine

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here